Gilead Sciences (BUE:GILD) Accumulated Depreciation : ARS-884,089 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Gilead Sciences Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Gilead Sciences's quarterly accumulated depreciation stayed the same from Jun. 2023 (ARS0 Mil) to Sep. 2023 (ARS0 Mil) but then increased from Sep. 2023 (ARS0 Mil) to Dec. 2023 (ARS-884,089 Mil).

Gilead Sciences's annual accumulated depreciation increased from Dec. 2021 (ARS-191,174 Mil) to Dec. 2022 (ARS-366,483 Mil) and increased from Dec. 2022 (ARS-366,483 Mil) to Dec. 2023 (ARS-884,089 Mil).

Gilead Sciences Accumulated Depreciation Historical Data

The historical data trend for Gilead Sciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Accumulated Depreciation Chart

Gilead Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-84,998.06

-135,741.84

-191,174.07

-366,482.89

-884,089.00

Gilead Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial															-366,482.89	-	-	-	-884,089.00

Gilead Sciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Gilead Sciences Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences (BUE:GILD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BUE:GILD) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GIS:Germany GIS:Germany GIS:Germany GILD34:Brazil GILD:Austria

Address

333 Lakeside Drive, Foster, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.